CUSIP 00773U207COM NEWAVU0Q3 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ3 2025
49 funds hold this security · Q3 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bml Capital Management, LLC | 3.06M | $13.85M | 0 | Held |
| 2 | Principia Wealth Advisory, LLC | 2.08M | $9.41M | +48.8K | Added |
| 3 | Frazier Life Sciences Management, L.P. | 2.08M | $9.41M | +1.01M | Added |
| 4 | Tcg Crossover Management, LLC | 1.67M | $7.56M |
| −128.3K |
| Reduced |
| 5 | Vanguard Group Inc | 872.0K | $3.95M | −11.9K | Reduced |
| 6 | 5am Venture Management, LLC | 541.7K | $2.45M | 0 | Held |
| 7 | Goldman Sachs Group Inc | 402.6K | $1.82M | −94.7K | Reduced |
| 8 | Renaissance Technologies LLC | 363.5K | $1.65M | −207.2K | Reduced |
| 9 | Pale Fire Capital Se | 363.3K | $1.65M | +4.6K | Added |
| 10 | Millennium Management LLC | 324.4K | $1.47M | −17.9K | Reduced |
See every fund holding Adverum Biotechnologies Inc, with full quarter-over-quarter share changes.
Unlock all holders